ArticleCancer genomics & proteomics

Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients.

Mitsukuni Suenaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.